New cancer clinical trial: Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Published on: September 27, 2018 at 12:00PM
Condition:   Adenocarcinoma of the Prostate
Intervention:   Biological: sipuleucel-T
Sponsors:   Dendreon;   PRA Health Sciences
Not yet recruiting
https://ift.tt/2zBPUP4